Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and Opportunistic Infections

isoxazoles has been researched along with Opportunistic Infections in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baron, G; Combe, B; Constantin, A; Dernis, E; Dougados, M; Flipo, RM; Gottenberg, JE; Mariette, X; Morel, J; Ravaud, P; Rist, S; Saraux, A; Schaeverbeke, T; Sibilia, J; Soubrier, M; Vittecoq, O1
Goodman, D; Hill, P; Jaw, J1
Barbera, RF; Chuluyan, JC; Colombini, AC; Orden, AO1
Butts, RJ; Savage, AJ; Uber, WE1
Erzen, D; Hocevar, A; Lestan, B; Petric, V; Praprotnik, S; Rozman, B; Tomsic, M1
Aneja, R; Arya, V; Dhir, V; Galle, A; Grover, R; Kumar, A; Marwaha, V1
Bruyn, GA; De Vries, M; Houtman, PM; Jansen, TL; Ten Brinke, A; van Roon, EN1

Other Studies

7 other study(ies) available for isoxazoles and Opportunistic Infections

ArticleYear
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE.
    Rheumatology (Oxford, England), 2017, 10-01, Volume: 56, Issue:10

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Drug Therapy, Combination; Female; France; Humans; Incidence; Isoxazoles; Leflunomide; Leukocyte Count; Male; Middle Aged; Neutrophils; Opportunistic Infections; Peptides, Cyclic; Proportional Hazards Models; Registries; Risk Factors

2017
Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Nephrology (Carlton, Vic.), 2017, Volume: 22, Issue:4

    Topics: Aged; BK Virus; Drug Substitution; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Middle Aged; Opportunistic Infections; Polyomavirus Infections; Time Factors; Treatment Outcome; Tumor Virus Infections; Viral Load

2017
Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis.
    Rheumatology international, 2012, Volume: 32, Issue:1

    Topics: Antirheumatic Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dermatomyositis; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Middle Aged; Opportunistic Infections; Treatment Outcome

2012
Treatment of BK viremia in a pediatric heart transplant recipient.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2012, Volume: 31, Issue:5

    Topics: Antiviral Agents; BK Virus; Child; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Kidney Diseases; Leflunomide; Opportunistic Infections; Tacrolimus; Treatment Outcome; Viral Load; Viremia

2012
Leflunomide-associated tuberculosis?
    Rheumatology (Oxford, England), 2006, Volume: 45, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Opportunistic Infections; Tuberculosis, Pulmonary

2006
Severe infections following leflunomide therapy for rheumatoid arthritis.
    Rheumatology (Oxford, England), 2006, Volume: 45, Issue:7

    Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Middle Aged; Opportunistic Infections; Tuberculosis, Spinal

2006
Cavitating pneumonia, a severe complication of leflunomide therapy in chronic polyarthritis.
    Rheumatology (Oxford, England), 2007, Volume: 46, Issue:3

    Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Opportunistic Infections; Pneumonia, Bacterial; Prospective Studies

2007